Farringdon Capital’s Qiagen QGEN Stock Holding History

Farringdon Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,296	Closed	-$415K	–	609
2025 Q3	$415K	Buy	+9,296	New	+$445K	0.11%	275
2025 Q1	–	Sell	-6,754	Closed	-$309K	–	561
2024 Q4	$309K	Buy	+6,754	New	+$302K	0.13%	271

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Farringdon Capital's QGEN Position: Q4 2025 in Review

Farringdon Capital sold out of Qiagen (QGEN) in Q4 2025, closing a stake of 9,296 shares — an estimated $415K sold.

Farringdon Capital first reported a position in QGEN in Q4 2024 and held it in 2 quarters. The position peaked at $415K in Q3 2025. 320 funds tracked by Wall St. Rank hold QGEN as of Q4 2025.

Farringdon Capital reported no remaining Qiagen position as of Q4 2025 after selling out during the quarter.
Farringdon Capital sold 9,296 Qiagen shares in Q4 2025, an estimated $415K.
Farringdon Capital first reported a position in Qiagen in Q4 2024 and held it in 2 quarters.
Farringdon Capital's Qiagen position peaked at $415K in Q3 2025.
320 funds tracked by Wall St. Rank held Qiagen as of Q4 2025.

Based on Farringdon Capital's 13F filing for Q4 2025, filed 17 Feb 2026.